EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 2 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,686 | -63.1% | 496 | -20.1% | 0.00% | -100.0% |
| Q2 2023 | $4,563 | -29.1% | 621 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6,433 | -12.3% | 621 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $7,333 | -43.6% | 621 | 0.0% | 0.00% | -66.7% |
| Q3 2022 | $13,000 | -31.6% | 621 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $19,000 | -26.9% | 621 | -2.2% | 0.00% | 0.0% |
| Q1 2022 | $26,000 | -42.2% | 635 | -38.2% | 0.00% | -42.9% |
| Q4 2021 | $45,000 | -29.7% | 1,027 | -20.1% | 0.01% | -36.4% |
| Q3 2021 | $64,000 | -92.4% | 1,285 | -90.4% | 0.01% | -91.9% |
| Q2 2021 | $843,000 | -81.9% | 13,380 | -73.3% | 0.14% | -82.9% |
| Q1 2021 | $4,662,000 | +8.6% | 50,189 | +4.8% | 0.80% | +7.3% |
| Q4 2020 | $4,291,000 | -13.5% | 47,887 | -0.2% | 0.74% | -20.2% |
| Q3 2020 | $4,959,000 | +36.2% | 47,995 | +4.3% | 0.93% | +29.1% |
| Q2 2020 | $3,640,000 | – | 46,030 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |